• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于筛查中国老年人群非酒精性脂肪性肝病的新型指标:一项基于人群的研究。

A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.

作者信息

Yang Huanhuan, Chen Guochong, Song Chunli, Li Deming, Ma Qinghua, Chen Guangliang, Li Xinli

机构信息

School of Public Health, Medical College of Soochow University Preventive Medicine Department, The Third People's Hospital of Xiangcheng District in Suzhou Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Soochow University, Suzhou, Jiangsu, PR China.

出版信息

Medicine (Baltimore). 2018 Mar;97(13):e0272. doi: 10.1097/MD.0000000000010272.

DOI:10.1097/MD.0000000000010272
PMID:29595690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5895391/
Abstract

Presently noninvasive methods were employed to the diagnosis of nonalcoholic fatty liver disease (NAFLD), including fatty liver index (FLI), hepatic steatosis index (HSI), product of fasting triglyceride and glucose levels (TyG), and single nucleotide polymorphism (SNP), whereas the accuracy of those indexes need to be improved. Our study aimed to investigate the feasibility of a new index comprehensive index (CI), consisting of 6 serum biomarkers and anthropometric parameters through multivariate logistic regression analysis, to the earlier detection of NAFLD, and the diagnostic value of 5 SNPs (S1: rs2854116 of apolipoprotein C3 [APOC3], S2: rs4149267 of ATP-binding cassette transporter [ABCA1], S3: rs13702 of lipoprotein lipase [LPL], S4: rs738409 of protein 3 [patatin-like phospholipase domain containing protein 3 (PNPLA3)], S5: rs780094 of glucokinase regulatory protein gene [GCKR]) for NAFLD were also explored. Area under the receiver operating characteristic curves (AUROC) and Youden index (YI) were calculated to assess the diagnostic value. The AUROC of CI was higher than FLI, HSI, and TyG (CI: 0.897, FLI: 0.873, HSI: 0.855, TyG: 0.793). Therefore, CI might be a better index for the diagnosis of NAFLD. Although there had no statistical significance (P = .123), the AUROC and YI were increased when CI combined with rs2854116 (S1) (AUROC = 0.902, YI = 0.6844). The combination of CI with S1 showed even better diagnostic accuracy than CI, which suggests the potential value of rs2854116 for the diagnosis of NAFLD.

摘要

目前,非侵入性方法被用于非酒精性脂肪性肝病(NAFLD)的诊断,包括脂肪肝指数(FLI)、肝脂肪变性指数(HSI)、空腹甘油三酯与血糖水平乘积(TyG)以及单核苷酸多态性(SNP),然而这些指标的准确性有待提高。我们的研究旨在通过多因素逻辑回归分析,探讨一种由6种血清生物标志物和人体测量参数组成的新指标综合指数(CI)用于早期检测NAFLD的可行性,并探索5个单核苷酸多态性(S1:载脂蛋白C3 [APOC3] 的rs2854116,S2:ATP结合盒转运体 [ABCA1] 的rs4149267,S3:脂蛋白脂肪酶 [LPL] 的rs13702,S4:蛋白3 [含帕他丁样磷脂酶结构域蛋白3(PNPLA3)] 的rs738409,S5:葡萄糖激酶调节蛋白基因 [GCKR] 的rs780094)对NAFLD的诊断价值。计算受试者工作特征曲线下面积(AUROC)和约登指数(YI)以评估诊断价值。CI的AUROC高于FLI、HSI和TyG(CI:0.897,FLI:0.873,HSI:0.855,TyG:0.793)。因此,CI可能是诊断NAFLD的更好指标。虽然无统计学意义(P = 0.123),但当CI与rs2854116(S1)联合时,AUROC和YI增加(AUROC = 0.902,YI = 0.6844)。CI与S1联合显示出比CI更好的诊断准确性,这表明rs2854116在NAFLD诊断中的潜在价值。

相似文献

1
A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder Chinese: A population-based study.一种用于筛查中国老年人群非酒精性脂肪性肝病的新型指标:一项基于人群的研究。
Medicine (Baltimore). 2018 Mar;97(13):e0272. doi: 10.1097/MD.0000000000010272.
2
APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.在中国汉族非酒精性脂肪性肝病患者中,载脂蛋白C3基因rs2070666与肝脂肪变性相关,且独立于帕他汀样磷脂酶域蛋白3基因rs738409。
Dig Dis Sci. 2016 Aug;61(8):2284-2293. doi: 10.1007/s10620-016-4120-7. Epub 2016 Apr 8.
3
Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.GCKR 和 PNPLA3 基因变异与肥胖个体非酒精性脂肪性肝病易感性相关。
Am J Clin Nutr. 2014 Apr;99(4):869-74. doi: 10.3945/ajcn.113.079749. Epub 2014 Jan 29.
4
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.载脂蛋白 PLA3 基因多态性对各种非侵入性标记物诊断和分期非酒精性脂肪性肝病的诊断性能的影响。
J Gastroenterol Hepatol. 2020 Jun;35(6):1057-1064. doi: 10.1111/jgh.14894. Epub 2019 Dec 9.
5
Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.中国汉族人群中载脂蛋白C3基因多态性与非酒精性脂肪性肝病风险之间无关联。
World J Gastroenterol. 2014 Apr 7;20(13):3655-62. doi: 10.3748/wjg.v20.i13.3655.
6
Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.加纳患者中脂肪肝生物标志物和胰岛素抵抗指数对非酒精性脂肪肝的预测价值。
Endocrinol Diabetes Metab. 2023 Nov;6(6):e456. doi: 10.1002/edm2.456. Epub 2023 Oct 9.
7
Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.葡萄糖激酶调节蛋白基因多态性影响非酒精性脂肪性肝病中的肝纤维化。
PLoS One. 2014 Feb 3;9(2):e87523. doi: 10.1371/journal.pone.0087523. eCollection 2014.
8
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.开发和验证一种基于临床和实验室的列线图,以预测非酒精性脂肪性肝病。
Hepatol Int. 2020 Sep;14(5):808-816. doi: 10.1007/s12072-020-10065-7. Epub 2020 Jun 22.
9
APOC3rs2854116, PNPLA3rs738409, and TM6SF2rs58542926 polymorphisms might influence predisposition of NAFLD: A meta-analysis.载脂蛋白 C3 基因 rs2854116、载脂蛋白 PLA3 基因 rs738409 和 TM6SF2 基因 rs58542926 多态性可能影响非酒精性脂肪性肝病的易感性:一项荟萃分析。
IUBMB Life. 2020 Aug;72(8):1757-1764. doi: 10.1002/iub.2302. Epub 2020 Jun 11.
10
Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.葡萄糖激酶调节蛋白(GCKR)基因变异与肥胖儿童和青少年的脂肪肝有关。
Hepatology. 2012 Mar;55(3):781-9. doi: 10.1002/hep.24806. Epub 2011 Dec 18.

引用本文的文献

1
The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis.甘油三酯-葡萄糖指数在代谢相关脂肪性肝病(MAFLD)中的诊断和预后价值:系统评价和荟萃分析。
Nutrients. 2022 Nov 23;14(23):4969. doi: 10.3390/nu14234969.
2
Advance of Serum Biomarkers and Combined Diagnostic Panels in Nonalcoholic Fatty Liver Disease.血清生物标志物和联合诊断标志物在非酒精性脂肪性肝病中的研究进展。
Dis Markers. 2022 Jun 29;2022:1254014. doi: 10.1155/2022/1254014. eCollection 2022.
3
Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity.

本文引用的文献

1
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者重复肝脏硬度测量与肝活检的比较。
Hepatol Int. 2018 Jan;12(1):44-55. doi: 10.1007/s12072-018-9843-4. Epub 2018 Jan 25.
2
Non-alcoholic fatty liver disease: an emerging predictor of stroke risk, severity and outcome.非酒精性脂肪性肝病:中风风险、严重程度及预后的新兴预测指标
Eur J Neurol. 2018 Apr;25(4):610-611. doi: 10.1111/ene.13584. Epub 2018 Feb 26.
3
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease.
开发一种针对超重或肥胖儿童代谢相关脂肪性肝病筛查的预测方案。
Pediatr Obes. 2022 Sep;17(9):e12917. doi: 10.1111/ijpo.12917. Epub 2022 Apr 8.
4
The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population.rs1260326 与老年汉族人群非酒精性脂肪性肝病风险的相关性及甘油三酯对非酒精性脂肪性肝病的中介作用。
Aging (Albany NY). 2022 Mar 25;14(6):2736-2747. doi: 10.18632/aging.203970.
5
Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.载脂蛋白 C3 多态性与非酒精性脂肪性肝病风险的关联:荟萃分析。
Afr Health Sci. 2020 Dec;20(4):1800-1808. doi: 10.4314/ahs.v20i4.34.
6
Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus.甘油三酯-血糖-腰围身高比:一种新型且有效的标志物,可用于识别 2 型糖尿病患者的肝脂肪变性。
Endocrine. 2021 Dec;74(3):538-545. doi: 10.1007/s12020-021-02815-w. Epub 2021 Aug 5.
7
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.载脂蛋白 L3(rs738409) 多态性与非酒精性脂肪性肝病的关系: 系统评价和荟萃分析。
BMC Endocr Disord. 2021 Jun 19;21(1):125. doi: 10.1186/s12902-021-00789-4.
8
Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population.中国北方汉族人群中GCKR基因多态性与非酒精性脂肪性肝病及冠状动脉疾病风险的关联
J Clin Transl Hepatol. 2019 Dec 28;7(4):297-303. doi: 10.14218/JCTH.2019.00030. Epub 2019 Dec 19.
9
Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study.禁食甘油三酯和血糖指数更适合用于识别中国成年人群中的代谢不健康个体:一项全国性研究。
J Diabetes Investig. 2019 Jul;10(4):1050-1058. doi: 10.1111/jdi.12975. Epub 2018 Dec 12.
10
Is possible to detect nonalcoholic fatty liver disease by a new index including single nucleotide polymorphisms (SNPs)?是否有可能通过一个包含单核苷酸多态性(SNP)的新指标来检测非酒精性脂肪性肝病?
Ann Transl Med. 2018 Sep;6(18):366. doi: 10.21037/atm.2018.09.20.
与非酒精性脂肪性肝病相关的过氧化物酶体增殖物激活受体
PPAR Res. 2017;2017:6561701. doi: 10.1155/2017/6561701. Epub 2017 Dec 5.
4
Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.台湾地区儿童肝脂肪变性和血清细胞角蛋白 18 片段水平的遗传决定因素。
Liver Int. 2018 Jul;38(7):1300-1307. doi: 10.1111/liv.13689. Epub 2018 Jan 24.
5
ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver.三磷酸腺苷结合盒转运蛋白 A 亚家族 8 是小鼠和人肝脏中胆固醇和牛磺胆酸盐的肝窦侧流出转运蛋白。
Mol Pharm. 2018 Feb 5;15(2):343-355. doi: 10.1021/acs.molpharmaceut.7b00679. Epub 2018 Jan 24.
6
The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.PNPLA3多态性的表达可能是西班牙裔人群非酒精性脂肪性肝病中严重肝脏疾病的关键因素。
Ann Hepatol. 2017;16(6):909-915. doi: 10.5604/01.3001.0010.5282.
7
Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD.鉴定日本男性 MTTP、PNPLA3 和 TM6SF2 中的有害罕见变异,并对其与 NAFLD 的关联进行研究。
Lipids Health Dis. 2017 Sep 26;16(1):183. doi: 10.1186/s12944-017-0570-y.
8
NAFLD: PNPLA3 and obesity: a synergistic relationship in NAFLD.非酒精性脂肪性肝病:PNPLA3与肥胖症:非酒精性脂肪性肝病中的协同关系
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):506-507. doi: 10.1038/nrgastro.2017.74. Epub 2017 Jun 14.
9
Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.代谢综合征患者非酒精性脂肪性肝病超声筛查的成本效益分析
Medicine (Baltimore). 2017 Apr;96(17):e6585. doi: 10.1097/MD.0000000000006585.
10
An extended fatty liver index to predict non-alcoholic fatty liver disease.一种用于预测非酒精性脂肪性肝病的扩展脂肪肝指数。
Diabetes Metab. 2017 Jun;43(3):229-239. doi: 10.1016/j.diabet.2016.11.006. Epub 2017 Jan 12.